Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(60%)

Phase Distribution

Ph phase_2
4
80%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 5 finished

Non-Completion Rate

100.0%

5 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Terminated(5)

Detailed Status

Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (80.0%)
Phase 31 (20.0%)

Trials by Status

terminated360%
withdrawn240%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_2

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

NCT00169221
terminatedphase_3

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

NCT00234468
withdrawnphase_2

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

NCT00233636
withdrawnphase_2

Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer

NCT00233623
terminatedphase_2

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

NCT00234442

Clinical Trials (5)

Showing 5 of 5 trials
NCT00169221Phase 2

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Terminated
NCT00234468Phase 3

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Terminated
NCT00233636Phase 2

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Withdrawn
NCT00233623Phase 2

Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer

Withdrawn
NCT00234442Phase 2

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5